🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareMy wife thinks I am crazy for doing this lol Page 2

My wife thinks I am crazy for doing this lol

DadBodDave Tue, Jan 27, 2026 at 10:32 AM 8 replies 902 viewsPage 2 of 2
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jan 28, 2026 at 9:07 PM#6
Dr.ObesityMed said:
Read four things before the headline number.

This is where I part company with the consensus forming above. I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them. The results probably generalise, and "probably" should be stated as an assumption rather than dropped.

16 11paul_denver, TinaHashiRN, robert_kc and 13 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jan 29, 2026 at 10:56 AM#7
DadBodDave said:
I keep finding that the number in the press summary and the number in the paper are not the same number, and the difference is always in the same…

Forest plot interpretation for the the trial evidence meta-analysis: when reading the pooled estimate, pay attention to:

  1. Point estimate (HR/RR/OR) — center of the diamond
  2. Confidence interval width — precision of the estimate
  3. I² statistic — heterogeneity across studies
  4. Individual study weights — are results driven by one large trial?
  5. Prediction interval — range of plausible true effects in future settings

The the trial evidence meta-analysis shows a pooled RR of 0.83 (95% CI 0.69-0.88), I²=56%. This is a robust and consistent effect.

15 10NauseaFreeNow, SteveThurs, B12Beth and 12 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Jan 30, 2026 at 12:46 AM#8
PharmD_Rodriguez said:
I would add the less popular caveat: these trial populations under-represented several groups, older adults and the highest BMI categories among them.

Propensity score matching studies and the trial evidence: when RCTs aren't available for a specific question, propensity score-matched observational studies can provide useful evidence.

A recent PSM study of 12,000 GLP-1 users vs matched controls showed reduced heart failure hospitalization (HR 0.74) over 3 years of follow-up[1].

These results complement the RCT data and suggest the benefits translate to real-world populations.

References:
[1] Registry-based cohort study, pre-print 2024.
Last edited: Jan 30, 2026 at 6:46 AM
14 9hans_munich, jason_sac26, chris_chi24 and 11 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DoseLogDan
Member
201
567
Feb 2025
Montana
Jan 30, 2026 at 2:36 PM#9

One thing that is still open after TirzTom’s answer:

How would you tell the difference between that and the alternative explanation?

13 8sophie_paris, mel_PDX, Dr.AddMedPHL and 10 others
Reply Quote Save Share Report
DadBodDave
Member
187
923
Nov 2024
Ohio
Feb 2, 2026 at 9:01 AM#10

Reporting back.

Update — my curve sits below the published mean and the explanation is that the trial arm had support I do not have. That was reassuring rather than otherwise.

Last edited: Feb 2, 2026 at 12:01 PM
23 23JakeBK_lifts, DerekSJ_a1c, paige_pharma and 20 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register